RBMX

Across TCGA pan-cancer cohorts, RBMX mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated RBMX data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RBMX mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated RBMX expression acts as an unfavorable survival marker, although some lineages such as COAD and LSCC show a favorable association.

COAD, LSCC, and HNSC are the cancer types where RBMX mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.889	.024	54	view →
LSCC	DFS	Quartile	All	1.000	0.894	.008	28	view →
HNSC	DFS	Tertile	IV	0.543	0.851	.017	13	view →
LUAD	OS	Tertile	All	1.000	0.668	.008	9	view →
GBM	OS	Quartile	All	0.535	0.307	.009	8	view →
OV	DFS	Median	All	0.867	1.000	.039	4	view →
PDAC	OS	Median	All	0.788	0.847	.025	2	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RBMX–COAD (DFS)

Open the COAD breakdown →